Canada · Venture startup

Who invested in Cynapsus Therapeutics

5 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 31 Oct 2026

$37Mraised across 5 rounds since 2012, from 5 sources

$940KDebt$4.1MVenture$15MVenture$500KGrant$17MVenture
Latest round
Venture, $17MMar 2015
Step-upi
33.2×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201320142015
$940KDebt$4.1MVenture$15MVenture$500KGrant$17MVenture
First round
Debt, $940K
Mar 2012
Biggest round
$17M
Venture · Mar 2015
Usual gap between rounds
12 months
the median of 4

The rounds

  1. Mar 2015
    Venture$17M3 new

    From a historical funding recordSEC filing: $17M sold, first sale Mar 2015

  2. Jul 2014
    Grant$500K

    No investor was named in the report.

    From a historical funding recordSEC filing: $15M sold, first sale Apr 2014

  3. Apr 2014
    Venture$15M

    No investor was named in the report.

    From a historical funding recordSEC filing: $15M sold, first sale Apr 2014

  4. Mar 2013
    Venture$4.1M

    No investor was named in the report.

    Reported by sec.govSEC filing: $4.1M sold, first sale Mar 2013

  5. Mar 2012
    Debt$940K

    No investor was named in the report.

    Reported by docs.google.comSEC filing: $940K sold, first sale Sept 2011

Founders and team

From Cynapsus Therapeutics's own website: 3 on the team.

  • Anthony J. GiovinazzoPresident & CEO, Director
  • Andrew WilliamsChief Operating Officer and Chief Financial Officer
  • Dr. Albert AgroChief Medical Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2012Venture2013Venture2014Grant2014Venture2015VenrockOrbiMedAisling Capital

Everyone who backed them

VenrockVC firm1round
OrbiMedPrivate equity1round
Aisling CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Cynapsus Therapeutics

Who invested in Cynapsus Therapeutics?

Cynapsus Therapeutics's investors include Venrock, OrbiMed and Aisling Capital.

How much has Cynapsus Therapeutics raised?

Cynapsus Therapeutics has raised $37M across 5 rounds since 2012.

When did Cynapsus Therapeutics last raise?

Cynapsus Therapeutics's most recent round was a Venture of $17M in Mar 2015.

What was Cynapsus Therapeutics's biggest round?

Its most recent round, $17M in Mar 2015, is also its largest on record.

Who backed Cynapsus Therapeutics first?

Cynapsus Therapeutics's first round on record, in Mar 2015, was backed by Venrock, OrbiMed and Aisling Capital.

What stage is Cynapsus Therapeutics at?

Cynapsus Therapeutics's latest named round is a Venture, in Mar 2015.

Where is Cynapsus Therapeutics based?

Cynapsus Therapeutics is based in Canada.

Companies like Cynapsus Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.